Journal profile · SUBSTANCE ABUSE
Substance Abuse Treatment Prevention and Policy
ISSN 1747-597X · Springer Nature · United Kingdom
Substance Abuse Treatment Prevention and Policy: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.39; fully open access; APC about USD 3,190; median 230 days to acceptance (105 articles, last 24 months); 56 articles in 2025; indexed in SSCI and Scopus.
Scope
Aims, scope and focus
Substance Abuse Treatment Prevention and Policy is published by Springer Nature and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment and HIV, Drug Use, Sexual Risk, together about 59.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Substance Abuse Treatment, Prevention, and Policy is an open access, peer-reviewed journal that encompasses research concerning substance abuse, with a focus on policy issues. The journal aims to provide an environment for the exchange of ideas, new research, consensus papers, and critical reviews, to bridge the established fields that share a mutual goal of reducing the harms from substance use. These fields include: legislation pertaining to substance use; correctional supervision of people with substance use disorder; medical treatment and screening; mental health services; research; and evaluation of substance use disorder programs.
From the journal's Aims & Scope
Research area (LetPub): SUBSTANCE ABUSE
Editor-in-chief Rhys PontonPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Substance Abuse Treatment and OutcomesMedicine28.6%
- Opioid Use Disorder TreatmentMedicine16.5%
- HIV, Drug Use, Sexual RiskMedicine14.2%
- Smoking Behavior and CessationMedicine5.3%
- Forensic Toxicology and Drug AnalysisPharmacology, Toxicology and Pharmaceutics4.2%
- Alcohol Consumption and Health EffectsMedicine3.3%
- Health Policy Implementation ScienceHealth Professions2.5%
- Prenatal Substance Exposure EffectsMedicine2.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Substance Abuse | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
Top journal: noReview journal: no
Database indexing
SSCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEMEDLINEPsycINFOCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.39LetPub ·
- Impact factor (publisher) 2025
- 3.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.8Publisher website ·
- CiteScore 2026-06
- 5.4LetPub ·
- SJR 2026-06
- 1.01LetPub ·
- SNIP 2026-06
- 1.2LetPub ·
- h-index
- 80OpenAlex ·
- i10-index
- 688OpenAlex ·
- 2-year mean citedness
- 2.81OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 55LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 1,200,000Publisher website ·
Articles by year OpenAlex count · 1,087 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 74 | 74 | 16 |
| 2025 | 56 | 56 | 153 |
| 2024 | 48 | 48 | 332 |
| 2023 | 73 | 73 | 889 |
| 2022 | 82 | 82 | 1,167 |
| 2021 | 91 | 91 | 2,287 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
230 daysMedian, submission to acceptance · P25–P75 167 days – 280 days
- Acceptance to online
- median 17 days (105 articles)
- Submission to online
- median 251 days
- Sample
- 105 articles with submission and acceptance dates (132 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 19 weeksLetPub ·
- Submission to first decision
- 42 daysPublisher website ·
- Submission to publication (journal-reported)
- about 19 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,790 / USD 3,190 / GBP 2,390 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 3,090 / EUR 2,690 / GBP 2,290 | — | — | |
| LetPub | GBP 2,190 / USD 2,990 / EUR 2,590 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAI use
- AI use Assessment of drug harm by final-year medical students and ChatGPT – a comparative analysis
Isak NäslundMichael OttUrsula Werneke Research Open access 12 September 2026
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1747-597X
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Substance Abuse Treatment Prevention and Policy
What CAS zone is Substance Abuse Treatment Prevention and Policy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Substance Abuse Treatment Prevention and Policy is in Zone 3 of Medicine, and in Zone 3 of the minor category Substance Abuse. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Substance Abuse Treatment Prevention and Policy?
The latest impact factor listed by LetPub is 3.39; CiteScore 5.4, h-index 80.
How long does peer review take at Substance Abuse Treatment Prevention and Policy?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 230 days (interquartile range 167–280 days); authors report an average review time of about 19 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Substance Abuse Treatment Prevention and Policy?
According to LetPub and DOAJ records, Substance Abuse Treatment Prevention and Policy is indexed in SSCI, Scopus and DOAJ. The journal's website also lists SCIE, MEDLINE, PsycINFO and CAS; that list has not been checked against each database.
Is Substance Abuse Treatment Prevention and Policy open access, and what is the APC?
Substance Abuse Treatment Prevention and Policy is a fully open-access journal. APC about USD 3,190.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .